Dr. Mark Joseph Hobeika M.D.

Recommended Articles

• Limit Your Risk for Prostate Cancer with Statins

  A recent study has shown that the levels of prostate specific antigen (PSA), a marker of prostate cancer, lower in men who take statin drugs. This may lower the risk of advanced prostate cancer in men, according to a study published in the Journal of the National Cancer Institute.High levels of PSA...

• What Does the Hypothalamus Do?

  Where is the hypothalamus located?The hypothalamus is a small, almond-sized, cone-shaped structure that projects downwards, ending in the infundibular stalk of the brain. This is a tubular connection to the pituitary gland, with which it has a direct relationship. The two are connected by nervous...

• What are Hot Flashes?

  Hot flashes are a sensation of warmth that is often followed by sweating, particularly in the neck and the face. These are normally seen in women who are permenopausal or in the menopausal stage. Hot flashes result in a flushed face and mostly occurs in the night. Some women report to have chills...

• What to Expect During Your Third Trimester of Pregnancy

  Fetal ActivityDuring this stage, a lot of fetal activity happens. These include poking and kicking, which you’ll find difficult not to notice. Breasts Continue to GrowContinued breast growth is expected until the third trimester. As the tissues grow, a yellow discharge called colostrums leaks...

• Can Physical Therapy Treat Multiple Sclerosis?

  Physical therapy (PT) is vital in the rehabilitation as well as conservation of important functional abilities for somebody with multiple sclerosis. Since multiple sclerosis varies from individual to individual (and the disability progresses over time), it is essential for a physical therapist to...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...